Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03161067 · ClinicalTrials.gov registry record · NA

Investigation on the Bidirectional Cortical Neuroprosthetic System

A NA study of Tetraplegia and Quadriplegia, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT03161067 is a NA study of Tetraplegia and Quadriplegia that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 5 participants, below the 19-participant average among 23 other Tetraplegia trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03161067, a NA study of Tetraplegia and Quadriplegia, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

The Bidirectional Cortical Neuroprosthetic System (BiCNS) consists of NeuroPort Microelectrode Array Systems and NeuroPort Electrodes (Sputtered Iridium Oxide Film), Patient Pedestals, the NeuroPort BioPotential Signal Processing System, and the CereStim C96 Programmable Stimulator. The goals of this early feasibility study consist of safety and efficacy evaluations of this device.

Conditions Studied

Interventions

  • DEVICE BiCNS

Study Locations (1)

Maryland

  • Department of Neurology - Baltimore

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2017-08-01
Est. Completion 2027-09-30
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT03161067

The ClinicalTrials.gov registry entry for NCT03161067 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 19-participant average among 23 other Tetraplegia trials with a reported enrollment target (74% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Tetraplegia appearing as the primary indexed condition, and to 1 intervention - of which BiCNS is the first listed.

NCT03161067 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03161067 about?

NCT03161067 is a clinical study titled "Investigation on the Bidirectional Cortical Neuroprosthetic System". The Bidirectional Cortical Neuroprosthetic System (BiCNS) consists of NeuroPort Microelectrode Array Systems and NeuroPort Electrodes (Sputtered Iridium Oxide Film), Patient Pedestals, the NeuroPort BioPotential Signal Processing System, and the CereStim C96 Programmable Stimulator. The goals of thi...

What is the current status of trial NCT03161067?

This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2017-08-01. Estimated completion is 2027-09-30.

What conditions does trial NCT03161067 study?

This clinical trial studies the following conditions: Tetraplegia, Quadriplegia.

What interventions are being tested in trial NCT03161067?

The interventions under investigation include: BiCNS (DEVICE).

Who is sponsoring clinical trial NCT03161067?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03161067 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tetraplegia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.